Search Press releases Keywords From To 9 Sep 2026 UCB receives U.S. FDA Breakthrough Therapy Designation for CIMZIA[®] (certolizumab pegol) in pregnant women with antiphospholipid syndrome (APS) Read More 8 Sep 2026 UCB opens ‘Expressing Epilepsy’ art exhibition featuring acclaimed artists living with epilepsy Read More 1 Sep 2026 UCB presents data at EEC 2026 highlighting continued leadership in epilepsy and developmental and epileptic encephalopathies Read More 31 Aug 2026 UCB Comes to Agreement with U.S. Government to Lower the Cost of Medicine and Strengthen U.S. Manufacturing Read More 31 Aug 2026 Transparency notification Wellington Management Group LLP Read More 30 Jul 2026 UCB Delivers Strong Results, Raises 2026 Guidance and Positions for Next Growth Phase Read More Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Page 1 of 66 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe